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Abstract Striated muscle tropomyosin is classically described
as consisting of 10 exons, 1a, 2b, 3, 4, 5, 6b, 7, 8, and 9a/b, in
both skeletal and cardiac muscle. A novel isoform found in
embryonic axolotl heart maintains exon 9a/b of striated muscle
but also has a smooth muscle exon 2a instead of exon 2b.
Translation and subsequent incorporation into organized myofi-
brils, with both isoforms, was demonstrated with green
fluorescent protein fusion protein construct. Mutant axolotl
hearts lack sufficient tropomyosin in the ventricle and this
smooth/straited chimeric tropomyosin was sufficient to replace
the missing tropomyosin and form organized myofibrils. , 2002
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Alternative RNA splicing is a fundamental process in eu-
karyotes that contributes to tissue-speci¢c and developmen-
tally regulated patterns of gene expression [1^5]. It is now
well established that vertebrate cardiac tissues produce both
striated (sarcomeric) and smooth muscle type tropomyosin,
each of which is 284 amino acids in length. In addition, small-
er isoforms of tropomyosin (cytoplasmic and ¢broblastic) of
248 amino acid residues are also produced in cardiac tissues
[2,6,7]. Only striated muscle isoforms contain troponin-bind-
ing domains (exon 9a/b). There are four tropomyosin genes
(K, L, TPM3, and TM4), which exhibit a high degree of con-
servation in species ranging from Drosophila to human. Com-
plex and diverse expression of tropomyosin isoforms has
made it di⁄cult to understand tropomyosin function in car-
diac muscle. There also may be di¡ering roles of speci¢c tro-
pomyosin isoforms in development and maintenance of the
myo¢bril. Tropomyosin is among ¢ve major proteins (actin,
tropomyosin, troponin-T, troponin-C, and troponin-I) that
comprise the thin ¢lament in striated muscle.
Previous studies of the K-TM gene, using Northern blot
analysis and RNase protection assay, identi¢ed the expression
of 10 isoforms of TM generated by alternate splicing of exons.
One isoform of the 10, comprised of exons 1a, 2b, 3, 4, 5, 6b,
7, 8, and 9a/b, is known to be speci¢c for striated, skeletal and
cardiac muscles. Several other isoforms were characterized as
tissue-speci¢c and/or developmentally speci¢c [3,5,8]. Re-
cently, Cooley and Bergstrom [9] used a highly sensitive
RT-PCR based strategy to report the expression of these
and many other new isoforms in a variety of adult rat tissues.
Previously, we reported the expression of a novel isoform of
K-TM, containing exons 1a, 2a (instead of 2b), 3, 4, 5, 6b, 7,
8, 9a/b in the Mexican axolotl [10]. The new TM isoform was
designated ATmC-2 (axolotl tropomyosin cardiac-2). Nucleo-
tide sequence analysis of ATmC-1 (striated muscle type iso-
form) and ATmC-2 strongly suggests that these two isoforms
are alternatively spliced isoforms of the K type TM gene in
Mexican axolotl. Expression of ATmC-2 was higher than
ATmC-1 in cardiac tissues [10,11].
Vertebrate hearts of the Mexican axolotl express the unique
tropomyosin isoform, which also maintains exon 9a/b found
in vertebrate striated muscle and is involved with troponin
binding. However, this novel isoform (ATmC-2) has a smooth
muscle type exon 2a. Currently there is a paucity of isoform-
speci¢c antibodies that may be used to study the diverse tro-
pomyosin isoforms, particularly one containing both smooth
and striated muscle exons. Due to the lack of a speci¢c anti-
body for ATmC-2, it is impossible to establish whether the
newly discovered ATmC-2 transcript is translatable in vivo.
Furthermore, it cannot be determined by immunolocalization
whether this isoform is incorporated into organized myo¢brils
like normal striated muscle isoforms (ATmC-1). We ap-
proached these issues by creating green £uorescent protein
(GFP) fusion protein expression constructs with ATmC-2 or
ATmC-1. These expression constructs when transfected into
whole hearts or cultured cells would express GFP.ATmC-2 or
GFP.ATmC-1 fusion protein. Embryonic whole hearts of the
Mexican axolotl can be transfected with speci¢c constructs
while maintaining intercellular structure and communications.
Normal hearts were used to demonstrate translatability and
incorporation into organized myo¢brils. This animal model
also has a cardiac mutant that has reduced expression of
tropomyosin in the ventricle. This provided an interesting
perspective to determine if the naturally occurring smooth/
striated chimera TM isoform (ATmC-2) could promote the
formation of organized myo¢brils and thus prove functional.
Strong support for the incorporation of ATmC-2 isoform in
cardiac cells was demonstrated in isolated embryonic chick
cardiomyocytes. This report is the ¢rst to suggest that the
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newly discovered TM transcript from a smooth muscle type
exon 2 produces a protein that can incorporate into organized
myo¢brils.
2. Materials and methods
2.1. Embryo care
Normal and cardiac mutant axolotl embryos were obtained from
matings between heterozygous (+/cU+/c) animals from the Indiana
University axolotl colony and the axolotl colony at SUNY Upstate
Medical University. Animals were maintained in aquaria in 50% Hol-
freter’s solution (29 mM NaCl, 0.45 mM CaCl2, 0.33 mM KCl,
0.1 mM MgSO4 and 4.76 mM NaHCO3) and fed commercial salmon
pellets. The embryos were staged according to the standard staging
system [12].
2.2. Preparation of the pEGFP.ATmC-1 and pEGFP.ATmC-2
expression constructs
ATmC-1 and ATmC-2 cDNA were ampli¢ed by PCR using 5P-
TCG GAA TTC ATG GAC GTC ATC AAG AAG-3P (+ve) and
5P-CTG AAT TCT TAC ATT GAA GTC ATA TCG TTG TTG
AG-3P (3ve) primer-pair. The strategy for ampli¢cation and prepara-
tion of pEGFP constructs is shown in Fig. 1. The GFP was driven by
a CMV promoter and the TM was linked to the GFP at the carboxy
end in frame. We added an EcoRI restriction site at the 5P end of both
positive and negative primers. The ampli¢ed products were digested
with EcoRI and subsequently gel puri¢ed (Qiagen Inc.) following the
manufacturer’s protocol. The digested DNA was then ligated to the
EcoRI digested pEGFP vector (Clontech) with T4 DNA ligase (Gibco
BRL) and subsequently transfected into the competent Escherichia
coli cells (Invitrogen). After colony hybridization, the positive clones
were picked up and the DNA was prepared for sequence analysis
(Cornell University DNA sequencing facility, Ithaca, NY, USA).
The plasmid with correct orientation of insert cDNA was identi¢ed
for large scale DNA preparation and subsequent transfection assays
in axolotl hearts or in chicken cardiomyocytes.
2.3. Cationic liposome mediated transfection in whole hearts
Transfection of cDNA was performed according to previously pub-
lished methods [13]. Transfected whole hearts were maintained in
culture for ¢ve days.
Fig. 1. Strategy for making ATmC-1 and ATmC-2 GFP constructs.
Fig. 2. Transfection of pEGFP.ATmC-2 into live hearts of normal
axolotl. a: Detection of GFP fusion protein in a live normal heart
at zero time. No GFP was visible. b: GFP fusion protein in a live
normal heart at 48 h. Green £uorescence was found in or around
the nucleus (asterisk) and within the cytoplasm (arrows). c: Trans-
fected live normal heart at ¢ve days examined with a GFP ¢lter on
confocal laser scanning microscope. GFP protein was expressed
throughout the heart with incorporation into striated myo¢brils (ar-
rowheads). Bar, 20 Wm.
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2.4. Confocal microscopy
Whole mount immunostaining and confocal microscopy were per-
formed according to our published procedures [13]. GFP protein was
detected on the confocal laser scanning microscope using a speci¢c
GFP ¢lter while examining the live non-¢xed hearts. Monoclonal
tropomyosin antibody [14] was obtained from the Developmental
Studies Hybridoma Bank. Anti-GFP monoclonal and polyclonal anti-
bodies (Clontech) were used for double staining of GFP and contrac-
tile proteins after ¢xation. Anti-mouse rhodamine red secondary anti-
body and anti-rabbit FITC (Sigma, St. Louis, MO, USA) at a dilution
of 1:50 were used for detection of the primary antibodies in addition
to direct GFP detection. Whole hearts were mounted on slides in
BioRad Fluorogard antifade reagent. Specimens were viewed on a
BioRad MRC 1024ES confocal laser system mounted on a Nikon
Fig. 3. Formation of striated myo¢brils in whole mutant hearts. a: Mutant control heart stained with CH1 tropomyosin antibody. Tropomyo-
sin levels are low and no organized myo¢brils were found in ventricle. Bar, 20 Wm. b: Normal control heart stained with CH1 antibody. Sarco-
meric myo¢brils were visible throughout the heart. Bar, 20 Wm. c: Mutant heart transfected with pEGFP.ATmC-2 and stained with CH1 anti-
body. Sections of branching sarcomeric myo¢brils were visible (arrowheads). Bar, 20 Wm. d: Mutant heart transfected with pEGFP.ATmC-2
and stained with anti-GFP polyclonal antibody. Higher magni¢cation demonstrates expression in the whole heart and incorporation of the fu-
sion protein into periodic branching myo¢brils (arrowheads). Bar, 20 Wm. e: Mutant heart transfected with pEGFP.ATmC-1. Sections of sarco-
meric myo¢brils (arrowheads) were seen throughout the heart and tropomyosin levels were increased. Bar, 20 Wm. f: Higher magni¢cation of a
mutant heart transfected with pEGFP. ATmC-1 and stained with polyclonal anti-GFP antibody. Sarcomeric myo¢brils were throughout the
heart (arrowheads). Bar, 20 Wm.
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Eclipse E600 microscope. Control hearts and treated hearts were ex-
amined using identical confocal settings. A simultaneous or sequential
(double staining) Z-series was made for each. Digital image processing
was performed using Adobe Photoshop.
2.5. Transfection of chick cardiomyocytes
Chick cardiomyocytes were prepared from eight-day-old embryo-
nated eggs as described by Dabiri et al. [15]. The cells were transfected
after one day in culture using methods reported by Ayoob et al. [16].
The plasmids containing the two di¡erent isoforms of axolotl tropo-
myosin were constructed as described. The cardiomyocytes began to
express the GFP-tropomyosin isoforms of tropomyosin after 1 to
2 days post-transfection (GFP.ATmC-1, GFP.ATmC-2). Images of
live contracting myocytes were taken on a Nikon Diaphot 200 in-
verted £uorescence microscope with a phase 100X Planapochromat
objective. Images were acquired with a liquid-cooled CCD (C 4742-95
Hamamatsu, Bridgewater, NJ, USA). Photographic images were as-
sembled using Image Pro Plus (Media Cybernectics, Silver Spring,
MD, USA) and Adobe Photoshop (Adobe, Mountain View, CA,
USA).
3. Results and discussion
GFP fusion protein was detected in live whole hearts by
using a confocal laser scanning microscope with a green £uo-
rescence ¢lter (laser wavelength 488 nm, ¢lter 515). Detection
of GFP, which was attached to the ATmC-2 construct, dem-
onstrated that ATmC-2 could be translated in whole hearts.
Fig. 2a shows a live whole heart at zero time and examined
with the green £uorescence ¢lter. No GFP fusion protein is
detected at this time. Detection of GFP in the cytoplasm and
in or near the nucleus was found at 48 h after initiation of the
experiment (Fig. 2b). Traditionally most proteins are trans-
lated in the cytoplasm but recent studies [17] have shown that
some proteins may have nuclear translation. Analyses of the
48 h samples suggest nuclear presence of the fusion protein
but it is also possible that the newly synthesized protein ac-
tually surrounds the perimeter of the nucleus. At ¢ve days,
GFP protein was found in sarcomeric myo¢brils of the whole
hearts (Fig. 2c). Therefore ATmC-2 can be translated and
expression in the normal whole hearts indicated that the pro-
tein was incorporated into sarcomeric myo¢brils.
Ectopic over-expression of the GFP fusion protein does not
a¡ect the contractile activity of the normal hearts or isolated
cardiomyocytes. There has been some concern of GFP toxic-
ity in other systems but we have not detected that with the
systems used for these experiments.
Cardiac mutant axolotl hearts have reduced levels of sarco-
meric tropomyosin, no well-organized myo¢brils and no con-
tractions. Fig. 3a demonstrates a control heart stained with
CH1 antibody. A control normal heart with sarcomeric myo-
¢brils can be seen in Fig. 3b. Previously we have found that
classical TM-4 type tropomyosin found in embryonic axolotl
can replace the reduced tropomyosin and promote myo¢bril
formation. All three transcripts of axolotl tropomyosin,
ATmC-1, ATmC-2, and ATmC-3, have been found to be
present in mutant hearts. An interesting question arises then
of whether the chimeric ATmC-2 smooth/striated type tropo-
myosin that is naturally occurring could su⁄ciently replace
missing tropomyosin and promote the formation of organized
myo¢brils. We also completed the analysis by examining
transfection of a classical tropomyosin, ATmC-1, into mutant
hearts.
Mutant hearts transfected with pEGFP.ATmC-2 demon-
strated that ATmC-2 was expressed in the mutant hearts
and with evidence obtained from the CH1 tropomyosin stain-
ing we could determine that small sarcomeric myo¢brils were
formed (Fig. 3b,c). Anti-GFP antibody staining was used to
coincide with the CH1 processing of the transfected hearts.
GFP expression was fairly uniform throughout the whole
heart and higher magni¢cation of the GFP transfected mutant
heart better showed the periodicity of sarcomeric myo¢brils
(Fig. 3d). Therefore ATmC-2, a novel TM isoform with
smooth muscle type exon 2a, was determined to be incorpo-
Fig. 4. Transfection of pEGFP.ATmC-1 and pEGFP.ATmC-2 into
isolated chick cardiomyocytes. a: Embryonic chick cardiomyocytes
transfected with GFP.ATmC-1. The sarcomeres were about 2 Wm in
length and the ATmC-1 isoform incorporated into the thin ¢la-
ments of the chick. The dark circle inside the cell is the nucleus.
Scale= 10 Wm. b: Embryonic chick cardiomyocyte transfected with
GFP.ATmC-2. The sarcomeres were about 2 Wm in length and the
axolotl tropomyosin isoform (ATmC-2) was readily incorporated
into the thin ¢laments of the chick. The nuclei of the cardiomyo-
cytes were detected by their round negative images. Scale = 10 Wm.
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rated into myo¢brils in normal and mutant whole hearts. This
incorporation was detected ¢rst using a GFP ¢lter on live
hearts and secondly by anti-GFP polyclonal antibody.
Transfection of pEGFP.ATmC-1, which is the classical
form of K-tropomyosin, demonstrated that the levels of tro-
pomyosin protein had increased compared to the control mu-
tant and sarcomeric myo¢brils had formed (CH1 staining,
Fig. 3e). The presence of GFP protein, detected in this case
by anti-GFP antibody, demonstrated the expression of the
transfected construct and con¢rmed the fusion protein was
within sarcomeric myo¢brils (Fig. 3f).
CH1 monoclonal antibody recognizes only sarcomeric TM
with exon 9a/b [14]. Although ATmC-1 and ATmC-2 di¡er at
exon 2, both have exon 9a/b [10]. CH1 antibody most likely
can recognize both of the transfected isoforms.
Since this is the ¢rst description of the incorporation of
a tropomyosin with smooth muscle type exon 2 into myo¢-
brils, we also used a di¡erent animal model and method.
The constructs GFP.ATmC-1 and GFP.ATmC-2 were trans-
fected into chicken cardiomyocytes in culture. GFP.ATmC-1
was expressed and incorporated into striated myo¢brils.
GFP.ATmC-2 was also incorporated into the myo¢brils
with detection of the fusion protein (Fig. 4). Both patterns
of incorporation were similar with little di¡erences detected.
These results in cultured chick cardiomyocytes con¢rm the
results shown with axolotl whole hearts. The novel ATmC-2
protein can be incorporated into sarcomeric myo¢brils in
isolated culture or whole hearts, chick or amphibian. We
have isolated and characterized the ATmC-2 homologues
from rat, chicken and human hearts (results not shown).
Human and chicken ATmC-2 homologues, like ATmC-2,
can also be incorporated into cardiac myo¢brils in axolotl
whole hearts.
ATmC-1 and ATmC-2 transfected into mutant hearts
promoted the formation of striated myo¢brils. The primary
question remaining is what role the novel ATmC-2 plays
in cardiac myo¢brillogenesis and contractile activity. We be-
lieve smooth muscle type exon 2 in ATmC-2 may have devel-
opmental implications for the formation of myo¢brils. The
presence of a smooth muscle type exon may be involved in
transition of thin ¢laments in previously proposed multi-step
models of myo¢brillogenesis [18].
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